Fig. 9
From: Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients
Sensitivity of chemotherapy drugs. A-I Difference in the estimated IC50 levels of Rucaparib (A), Paclitaxel (B), Gemcitabine (C), Veliparib (D), Vinblastine (E), Vinorelbine (F), Bleomycin (G), Cisplatin (H), and Docetaxel (I). Data are shown as means ± S.D. ns: not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001